Biocon Competitors and Similar CompaniesClear all

Biocon's competitors and similar companies include EMS Pharma, Cipla and Idorsia.
Biocon
Biocon
Biocon is a global biopharmaceutical company.
EMS Pharma
EMS Pharma
EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
Cipla
Cipla
Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression, and cardiovascular diseases.
Idorsia
Idorsia
Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
Founding Date
Founding Date
1978
Founding Date
1964
Founding Date
1935
Founding Date
2017
Type
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Bengaluru, IN HQ
Bengaluru, IN
Hyderabad, IN
Visakhapatnam, IN
Dublin, IE
Kuala Lumpur, MY
Puchong, MY
see more
Locations
BR HQ
Locations
Mumbai, IN HQ
South Melbourne, AU
Mumbai, IN
Nairobi, KE
Cape Town, ZA
Durban, ZA
Durban, ZA
see more
Locations
Allschwil, CH HQ
Shanghai, CN
Lörrach, DE
Chiyoda City, JP
Employees
Employees
16,545
Employees
11,5961% increase
Employees
26,61516% increase
Employees
8007% increase
Twitter followers
Twitter followers
21.8 k
Twitter followers
1.2 k
Twitter followers
33.9 k
Twitter followers
2.1 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
41
Number of tweets (last 30 days)
12
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
4.1
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
2.9
Average likes per tweet (last 30 days)
3.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
65.85%
Percentage of tweets with engagement (last 30 days)
100%

Financial

Revenue (est.)
Revenue (est.)
₹109.3b (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
₹254.5b (FY, 2024)
Revenue (est.)
CHF97.1m (FY, 2022)
Cost of goods
Cost of goods
₹39.3b (FY, 2023)
Cost of goods
N/A
Cost of goods
₹88.2b (FY, 2024)
Cost of goods
CHF6.3m (FY, 2022)
Gross profit
Gross profit
₹78.5b (FY, 2023)
Gross profit
N/A
Gross profit
₹177b (FY, 2024)
Gross profit
CHF90.8m (FY, 2022)
Net income
Net income
₹6.4b (FY, 2023)
Net income
N/A
Net income
₹41.6b (FY, 2024)
Net income
(CHF827.9m) (FY, 2022)
For sources of this data, please see the company profile

View Company Profiles

EMS Pharma
HQ
BR
Employees
11,596↑ 1% increase

EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.

View company
Cipla
HQ
Mumbai, IN
Employees
26,615↑ 16% increase

Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression, and cardiovascular diseases.

View company
Idorsia
HQ
Allschwil, CH
Employees
800↑ 7% increase

Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.

View company